851314-55-1

Basic information

• Product Name: ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)aMino)-2,2-difluoropropanoate
• Synonyms: ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)aMino)-2,2-difluoropropanoate;N-(3-Ethoxy-2,2-difluoro-3-oxopropyl)-N-(phenylmethyl)-beta-alanine ethyl ester
• CAS NO: 851314-55-1
• Molecular Formula: C₁₇H₂₃F₂NO₄
• Molecular Weight: 343.3656264
• Mol File: 851314-55-1.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)aMino)-2,2-difluoropropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)aMino)-2,2-difluoropropanoate(851314-55-1)
• EPA Substance Registry System: ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)aMino)-2,2-difluoropropanoate(851314-55-1)

Safety Data

• Hazardous Substances Data: 851314-55-1(Hazardous Substances Data)

Usage

General Description

Ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)aMino)-2,2-difluoropropanoate is a chemical compound with a complex molecular structure. It consists of an ethyl ester group (ethyl 3-), a benzyl group, an aMino group, and a difluoropropanoate group. The compound also contains an ethoxy-oxopropyl substituent. This chemical may have potential pharmaceutical or medicinal applications, although further research and testing would be necessary to determine its specific uses and effects.

Upstream product

• 23583-21-3 ethyl-3-benzylamino propionate 
• 851314-54-0 ethyl N-(1H-1,2,3-benzotriazol-1-ylmethyl)-N-(phenylmethyl)-beta-alaninate 
• 667-27-6 Ethyl bromodifluoroacetate 

Downstream Products

• 1067914-81-1 3,3-difluoro-1-(phenylmethyl)-4,4-piperidinediol 
• 1067914-83-3 tert-butyl 3,3-difluoro-4,4-dihydroxypiperidine-1-carboxylate 
• 1067914-82-2 (±)-tert-butyl 4-(benzylamino)-3,3-difluoropiperidine-1-carboxylate 
• 1820679-70-6 (±)-tert-butyl 4-amino-3,3-difluoropiperidine-1-carboxylate 
• 851314-31-3 C₃₆H₃₅Cl₃F₄N₂O₄ 
• 851314-26-6 4-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-5,5-difluoro-1,2,5,6-tetrahydropyridine-3-carboxylic acid cyclopropyl-(2,3-dichlorobenzyl)amide 
• 851314-50-6 4-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-5,5-difluoro-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 851314-53-9 4-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-5,5-difluoro-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 
• 851314-47-1 5,5-difluoro-4-[4-(3-hydroxypropyl)phenyl]-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 1209780-71-1 tert-butyl 3,3-difluoro-4-hydroxy-piperidine-1-carboxylate 
• 1239596-54-3 3,3-difluoropiperidin-4-ol 
• 1233929-29-7 6,6-difluoro-N-phenyl-4-(phenylsulfonyl)-1-oxa-4,8-diazaspiro[4.5]decane-8-carboxamide 
• 1233932-23-4 6,6-difluoro-4-(phenylsulfonyl)-1-oxa-4,8-diazaspiro[4.5]decane 
• 1233932-22-3 8-benzyl-6,6-difluoro-4-(phenylsulfonyl)-1-oxa-4,8-diazaspiro[4.5]decane 

Relevant articles and documents

5-SUBSTITUTED DIFLUOROPIPERIDINE COMPOUND CAPABLE OF PASSING THROUGH BLOOD-BRAIN BARRIER

The present invention discloses 5-substituted difluoropiperidine compounds having a capacity to cross the blood-brain barrier; the compound has the structural formula represented by formula (I): The 5-substituted difluoropiperidine compounds, derivatives

Quinazoline derivative salt-type crystal forms and preparation method and application thereof

The invention discloses quinazoline derivative salt-type crystal forms and a preparation method and application thereof. The quinazoline derivative salt-type crystal forms are specifically the hydrochloride crystal forms A, B, C, D, F, H, I, the sulphate

HETEROCYCLIC COMPOUND

The present invention provides a compound having a superior JAK inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like, or a salt thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.